Clinical trial
Effects of Enzyme Replacement in Gaucher's Disease
NCT00001289 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00001289 |
|---|---|
| Title | Effects of Enzyme Replacement in Gaucher's Disease |
| Official title | Clinical and Biochemical Effects of Macrophage-Targeted Glucocerebrosidase on Neurological Involvement in Neuronopathic Gaucher's Disease |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Gaucher's Disease |
| Enrollment | 70 |
| Start date | Sep 23, 1991 |
| Completion | Mar 3, 2008 |
| First posted | Nov 4, 1999 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: